Tianyin Pharmaceutical, Co., which makes modernized versions of traditional Chinese medicine, released unaudited results from its fiscal 2008, which ended June 30, 2008. The company said its revenues climbed 65% to $33 million while net income was 50% higher at $5.9 million. Tianyin said its audited numbers will be announced by the end of September, and management will discuss them in a conference call at that time. More details...

Stock Symbol: (OTCBB: TYNP)